Mark S. Levine's Net Worth
$14.5 Million
Who is Mark S. Levine?
Mark S. Levine has an estimated net worth of $14.5 Million. This is based on reported shares across multiple companies, which include Immunovant, Inc., Flexion Therapeutics Inc, and Minerva Neurosciences, Inc..
SEC CIK
Mark S. Levine's CIK is 0001617236
Past Insider Trading and Trends
2017 was Mark S. Levine's most active year for acquiring shares with 4 total transactions. Mark S. Levine's most active month to acquire stocks was the month of February. 2024 was Mark S. Levine's most active year for disposing of shares, totalling 12 transactions. Mark S. Levine's most active month to dispose stocks was the month of December. 2017 saw Mark S. Levine paying a total of $173,370.00 for 160,000 shares, this is the most they've acquired in one year. In 2021 Mark S. Levine cashed out on 356,093 shares for a total of $1,236,083.02, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Immunovant, Inc. (IMVT) Snapshot price: $34
Chief Legal Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.33% | -4.36K |
$29.53 | -$128,780.33 | 322.88K |
Oct 23
| |||
Form 4
| -0.87% | -2.86K |
$28.79 | -$82,339.40 | 327.24K |
Oct 16
| |||
Form 4
| -0.99% | -3.29K |
$31.86 | -$104,975.68 | 330.1K |
Aug 21
| |||
Form 4
| -1.19% | -4.01K |
$27.76 | -$111,456.40 | 333.39K |
Jul 24
| |||
Form 4
| -0.74% | -2.50K |
$29.69 | -$74,381.97 | 337.41K |
Jul 17
| |||
Form 4
| -0.94% | -3.24K |
$29.65 | -$96,125.30 | 339.91K |
May 22
| |||
Form 4
| -1.14% | -3.96K |
$28.90 | -$114,530.70 | 343.16K |
Apr 24
| |||
Form 4
| -2.75% | -9.83K |
$29.06 | -$285,554.10 | 347.12K |
Apr 17
| |||
Form 4
| +18.21% | 54.98K |
—
|
—
| 356.95K |
Apr 2
| |||
Form 4
| -0.70% | -2.13K |
$36.15 | -$77,144.10 | 301.97K |
Feb 22
| |||
Form 4
| -0.99% | -3.03K |
$37.92 | -$114,778.41 | 304.1K |
Jan 26
| |||
Form 4
| -1.05% | -3.25K |
$32.78 | -$106,598.48 | 307.13K |
Nov 22
| |||
Form 4
| -1.31% | -4.11K |
$34.66 | -$142,348.62 | 310.38K |
Oct 25
| |||
Form 4
| -3.76% | -12.29K |
$20.30 | -$249,406.39 | 314.49K |
Aug 24
| |||
Form 4
| -1.18% | -3.92K |
$21.63 | -$84,724.71 | 326.77K |
Jul 26
| |||
Form 4
| -0.79% | -2.63K |
$16.29 | -$42,891.57 | 330.69K |
Apr 25
| |||
Form 4
| +35.69% | 87.66K |
—
|
—
| 333.32K |
Apr 12
| |||
Form 4
| -3.97% | -10.16K |
$18.51 | -$187,987.56 | 245.66K |
Jan 26
| |||
Form 4
| +78.89% | 112.82K |
—
|
—
| 255.82K |
Aug 17
| |||
Form 4
|
∞
| 143K |
—
|
—
| 143K |
Jan 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Flexion Therapeutics Inc No price found
General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -133.49K |
$8.50 | -$1,134,631.00 |
0
|
Nov 19
| |||
Form 4
| -2.87% | -3.94K |
$6.45 | -$25,445.25 | 133.49K |
Jul 19
| |||
Form 4
| +27.92% | 30K |
—
|
—
| 137.43K |
Mar 1
| |||
Form 4
| -5.98% | -6.83K |
$11.13 | -$76,006.77 | 107.43K |
Jan 5
| |||
Form 4
| +51.32% | 38.75K |
—
|
—
| 114.26K |
Jul 16
| |||
Form 4
| +1.37% | 1.02K |
$10.83 | $11,079.09 | 75.51K |
Jun 22
| |||
Form 4
| +71.29% | 31K |
—
|
—
| 74.49K |
Mar 2
| |||
Form 4
| -7.89% | -3.72K |
—
|
—
| 43.49K |
Jan 3
| |||
Form 4
| +2.69% | 1.21K |
$9.81 | $11,899.53 | 46.27K |
Jun 21
| |||
Form 4
| +397.35% | 36K |
—
|
—
| 45.06K |
Mar 1
| |||
Form 4
| -7.49% | -734.00 |
$12.36 | -$9,072.24 | 9.06K |
Scheduled
|
Jan 3
| ||
Form 4
| +6.47% | 539 |
$21.22 | $11,437.58 | 8.87K |
Jun 20
| |||
Form 4
|
∞
| 8.33K |
—
|
—
| 8.33K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Minerva Neurosciences, Inc. (NERV) Snapshot price: $2.65
SVP,General Counsel & Sec.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$8.10 | -$101,675.00 |
0
|
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
$8.36 | -$127,455.00 |
0
|
Scheduled
|
Jan 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||